Is the FDA Sneaking Through a “Future Framework” to Enable a New Direct-To-Consumer Pathway for Novel Pharma Drugs with Unacceptable Risk/Benefit Profiles?

June 28, 2022

New rule just released by FDA seeks to “broaden the types of drugs that can be approved as nonprescription” by adding a new mechanism for making prescription drugs OTC.

https://ashmedai.substack.com/p/is-the-fda-sneaking-through-a-future?utm_source=substack&utm_medium=email